Clinical Research Directory
Browse clinical research sites, groups, and studies.
Bleeding Patterns in Sequential and Continuous Progesterone Supplementation in Adolescents With Turner Syndrome
Sponsor: Children's Mercy Hospital Kansas City
Summary
This is a single-site open label non-randomized study comparing effects of sequential versus continuous use of progesterone supplementation amongst Turner Syndrome (TS) patients with primary ovarian insufficiency (POI) prescribed hormone replacement therapy (HRT).
Official title: Bleeding Patterns in Sequential and Continuous Progesterone Supplementation in Adolescents With Turner Syndrome: A Non-randomized Prospective Trial (The BOOST Study)
Key Details
Gender
FEMALE
Age Range
12 Years - 20 Years
Study Type
INTERVENTIONAL
Enrollment
40
Start Date
2025-07-31
Completion Date
2026-07-31
Last Updated
2025-09-04
Healthy Volunteers
No
Interventions
Micronized progesterone 200 MG
Oral micronized progesterone 200mg for the first 12 days of a 30 to 31-day cycle
Micronized Progesterone 100 MG
Oral micronized progesterone 100mg daily taken throughout the 30 to 31-day cycle.
Locations (1)
Children's Mercy Hospital
Kansas City, Missouri, United States